“Anakinra As Rescue Therapy to Treat Patients With Severe COVID-19 Refractory to Tocilizumab”. Archives of Clinical and Biomedical Research 5, no. 6 (December 10, 2021): 972–982. Accessed September 20, 2026. https://www.fortunejournals.org/ojs/index.php/acbr/article/view/14882.